Morbus Dupuytren: Epidemiologie, Diagnose, Therapie, Outcome : CME : zertifizierte Fortbildung
Dupuytren’s contracture is a fibroproliferative systemic disease that cannot be stopped by medication. The overall prevalence is 7-8%. Men are affected 3-4 times more frequently. The cause of the disease is not known. A genetic disposition and thus familial clustering are being discussed. Risk facto...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Deutsch |
| Veröffentlicht: |
November 2024
|
| In: |
Die Orthopädie
Year: 2024, Jahrgang: 53, Heft: 11, Pages: 893-902 |
| ISSN: | 2731-7153 |
| DOI: | 10.1007/s00132-024-04553-z |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00132-024-04553-z Verlag, lizenzpflichtig, Volltext: http://link.springer.com/article/10.1007/s00132-024-04553-z |
| Verfasserangaben: | A. Harbrecht, P. Honigmann, S. Löw, L.P. Müller, F. Unglaub, C.K. Spies |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1915162009 | ||
| 003 | DE-627 | ||
| 005 | 20250716223250.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250120s2024 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00132-024-04553-z |2 doi | |
| 035 | |a (DE-627)1915162009 | ||
| 035 | |a (DE-599)KXP1915162009 | ||
| 035 | |a (OCoLC)1528016654 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a ger | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Harbrecht, Andreas |d 1989- |e VerfasserIn |0 (DE-588)1170173195 |0 (DE-627)1037603621 |0 (DE-576)512407479 |4 aut | |
| 245 | 1 | 0 | |a Morbus Dupuytren |b Epidemiologie, Diagnose, Therapie, Outcome : CME : zertifizierte Fortbildung |c A. Harbrecht, P. Honigmann, S. Löw, L.P. Müller, F. Unglaub, C.K. Spies |
| 246 | 1 | |i Englischsprachiger Titel der Zusammenfassung |a Dupuytren’s disease. Epidemiology, diagnosis, treatment, outcome | |
| 264 | 1 | |c November 2024 | |
| 300 | |b Illustrationen | ||
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online publiziert: 25. September 2024 | ||
| 500 | |a Gesehen am 20.01.2025 | ||
| 520 | |a Dupuytren’s contracture is a fibroproliferative systemic disease that cannot be stopped by medication. The overall prevalence is 7-8%. Men are affected 3-4 times more frequently. The cause of the disease is not known. A genetic disposition and thus familial clustering are being discussed. Risk factors for the development of a Dupuytren’s contracture are work-related stress (microtrauma), nicotine and alcohol consumption, epilepsy and diabetes mellitus as well as advanced age. The prognosis is poor in cases with a positive family history, bilateral involvement, age <50 years and male gender. Several treatment options are available. Conservative therapy has no lasting benefit. Minimally invasive procedures include partial needle aponeurectomy or the injection of collagenase. Surgical procedures range from partial aponeurectomy to dermatoaponeurectomy. The recurrence risk of the gold standard treatment of surgery (partial aponeurectomy) is 20.9%. | ||
| 700 | 1 | |a Honigmann, Philipp |e VerfasserIn |4 aut | |
| 700 | 1 | |a Löw, Steffen |d 1972- |e VerfasserIn |0 (DE-588)123331994 |0 (DE-627)706259491 |0 (DE-576)293659737 |4 aut | |
| 700 | 1 | |a Müller, Lars Peter |e VerfasserIn |0 (DE-588)1113301740 |0 (DE-627)867166231 |0 (DE-576)476943345 |4 aut | |
| 700 | 1 | |a Unglaub, Frank |d 1974- |e VerfasserIn |0 (DE-588)124402518 |0 (DE-627)36332254X |0 (DE-576)294155422 |4 aut | |
| 700 | 1 | |a Spies, Christian |d 1977- |e VerfasserIn |0 (DE-588)133382516 |0 (DE-627)544038339 |0 (DE-576)299810054 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Die Orthopädie |d [Berlin] : Springer Medizin Verlag GmbH, 2022 |g 53(2024), 11 vom: Nov., Seite 893-902 |h Online-Ressource |w (DE-627)1808390040 |w (DE-600)3122958-X |x 2731-7153 |7 nnas |a Morbus Dupuytren Epidemiologie, Diagnose, Therapie, Outcome : CME : zertifizierte Fortbildung |
| 773 | 1 | 8 | |g volume:53 |g year:2024 |g number:11 |g month:11 |g pages:893-902 |g extent:10 |a Morbus Dupuytren Epidemiologie, Diagnose, Therapie, Outcome : CME : zertifizierte Fortbildung |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00132-024-04553-z |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://link.springer.com/article/10.1007/s00132-024-04553-z |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250120 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 124402518 |a Unglaub, Frank |m 124402518:Unglaub, Frank |d 60000 |e 60000PU124402518 |k 0/60000/ |p 5 | ||
| 999 | |a KXP-PPN1915162009 |e 4654244921 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1007/s00132-024-04553-z"],"eki":["1915162009"]},"name":{"displayForm":["A. Harbrecht, P. Honigmann, S. Löw, L.P. Müller, F. Unglaub, C.K. Spies"]},"titleAlt":[{"title":"Dupuytren’s disease. Epidemiology, diagnosis, treatment, outcome"}],"physDesc":[{"noteIll":"Illustrationen","extent":"10 S."}],"recId":"1915162009","type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["ger"],"note":["Online publiziert: 25. September 2024","Gesehen am 20.01.2025"],"title":[{"subtitle":"Epidemiologie, Diagnose, Therapie, Outcome : CME : zertifizierte Fortbildung","title":"Morbus Dupuytren","title_sort":"Morbus Dupuytren"}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"November 2024"}],"relHost":[{"pubHistory":["Volume 51, issue 6 (June 2022)-"],"origin":[{"publisherPlace":"[Berlin]","dateIssuedDisp":"[2022]-","publisher":"Springer Medizin Verlag GmbH"}],"note":["Gesehen am 28.06.2022"],"language":["ger","eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"subtitle":"Organ der Deutschen Gesellschaft für Orthopädie und Orthopädische Chirurgie : Organ der Deutschen Gesellschaft für Orthopädie und Unfallchirurgie : Organ der Österreichischen Gesellschaft für Orthopädie und orthopädische Chirurgie","title_sort":"Orthopädie","title":"Die Orthopädie"}],"part":{"volume":"53","year":"2024","extent":"10","text":"53(2024), 11 vom: Nov., Seite 893-902","issue":"11","pages":"893-902"},"id":{"eki":["1808390040"],"issn":["2731-7153"],"zdb":["3122958-X"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"1808390040","disp":"Morbus Dupuytren Epidemiologie, Diagnose, Therapie, Outcome : CME : zertifizierte FortbildungDie Orthopädie"}],"person":[{"family":"Harbrecht","given":"Andreas","role":"aut","display":"Harbrecht, Andreas"},{"display":"Honigmann, Philipp","given":"Philipp","role":"aut","family":"Honigmann"},{"role":"aut","given":"Steffen","family":"Löw","display":"Löw, Steffen"},{"display":"Müller, Lars Peter","role":"aut","given":"Lars Peter","family":"Müller"},{"display":"Unglaub, Frank","family":"Unglaub","given":"Frank","role":"aut"},{"family":"Spies","given":"Christian","role":"aut","display":"Spies, Christian"}]} | ||
| SRT | |a HARBRECHTAMORBUSDUPU2024 | ||